➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Johnson and Johnson
Colorcon
Mallinckrodt
Medtronic

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Network Appliance Inc. v. Sun Microsystems Inc (N.D. Cal. 2007)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Network Appliance Inc. v. Sun Microsystems Inc (N.D. Cal. 2007)

Docket   Start Trial Date Filed 2007-11-30
Court District Court, N.D. California Date Terminated 2010-09-09
Cause 35:145 Patent Infringement Assigned To Elizabeth D. Laporte
Jury Demand Both Referred To
Parties ADVANCED MICRO DEVICES, INC.; CHELSIO COMMUNICATIONS, INC.; JOYENT INC.; NETWORK APPLIANCE INC.; NEXENTA SYSTEMS, INC.; ORRICK, HERRINGTON & SUTCLIFFE, LLP; SUN MICROSYSTEMS INC; SYMANTEC CORPORATION; YAHOO! INC.
Patents 4,755,534; 6,039,892; 6,138,201; 8,017,352; 8,071,643
Attorneys Aaron Matthew Nathan; Azra M. Hadzimehmedovic; Benjamin Anthony Costa; Byron Cain Beebe; Carisa S Yee; Carrie Lynne Williamson; Christine Kerba Corbett; Claude Edward Welch; Clayton Edward Dark , Jr.; Clayton W. Thompson , II; Clyde Moody Siebman; Colette Vogele; Danielle Rosenthal; David J. Healey; David K. Caplan; David L. Alberti; Derek C. Walter; Douglas Robert Schwartz; Edward Robert Reines; Elizabeth Stotland Weiswasser; James G. Snell; Jason Michael Gonder; Jeffrey G. Homrig; Jill Jane Ho; Jill Jane Schmidt; Mark A. Flagel; Mark Fowler; Matthew Douglas Powers; Meryl Macklin; Patricia Young; Patricia Young ,; Robert Buergi; Steven Mark Levitan; Yakov M. Zolotorev
Firms Bingham McCutchen LLP; Haynes and Boone LLP; Hogan Lovells US LLP; Keats McFarland & Wilson LLP; Latham & Watkins LLP; Ridder, Costa & Johnstone LLP; Schwartz & Cera; TeleNAv Inc.; Vogele and Associates
Link to Docket External link to docket
Small Molecule Drugs cited in Network Appliance Inc. v. Sun Microsystems Inc
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Network Appliance Inc. v. Sun Microsystems Inc

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Network Appliance Inc. v. Sun Microsystems Inc (N.D. Cal. 2007)

Date Filed Document No. Description Snippet Link To Document
2008-07-21 115 Exhibit C ., Multi-resident AFS: An Adventure in 6,138,201 A 1012000 Rebalski …United States Patent (10) Patent NO.: US 7,…UNITED STATES PATENT AND TRADEMARK OFFICE CERTIFICATE OF CORRECTION PATENT NO. … appears in the above-identified patent and that said Letters Patent is hereby corrected as shown… (45) Date of Patent: Apr. 3,2007 (54) METHOD FOR WRITING CONTIGUOUS External link to document
2008-09-08 146 Motion to Stay States Patent No. 6,'892,211, pending completion of the PTO’s reexamination of this patent This motion…States Patent No. 6,892,211 (“the ’211 patent”) pending completion of the United States Patent and Trademark…211 patent (and two other patents) pending completion of the PTO’s reexamination of ‘ the patent. On …the ’211 patent has been deposed to date, and patent prosecution counsel for the ’211 patent have not … with respect to thApp’s ’211 patent, ’2'_92 patent and ’001 patent pending completion of the PTO’ External link to document
2008-04-15 35 Ex Parte Application 6,857,001 and 6',892,211 (collectively, “the Reexam Patents”). The PTO also already issued an Office Action…questions of patentability exist as to the other two patents. As such, none of the three Reexam Patents liker…(“N'e.tApp”) seven patents-in-suit into reexamination: United States Patent Nos. 5,819,292, 6,857,…one Reexam Patent, finding that ten separate pieces of prior art each invalidate the patent and found …to the Reexam Patents pending completion of the PTO’s reexamination of these three patents NetApp opposes External link to document
2008-04-15 39 Exhibit B number 08/071,643, now abandoned, filed 3 lurie 1993. A substantial new question of` patentability (SNQ… STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark…of U. S. Patent No. 6,8'92,211 to Hitz et al. issued on May 10, 2005. The 6,892,211 patent to Hitz… New Question of Patentability For "a substantial new question of` patentability’" (SNQ) to …prior art patents and or printed publications raise a substantial question of patentability regarding External link to document
2008-04-19 42 Exhibit Exhibit H (part 1) 1995 (now U.S. Patent No. 5,819,292), which is a continuation of Application No. 08/071,’643, filed June…gt;>Application Five:: 08/071,643 Filing Date:: ’ …in the parent of Hitz, namely application no. 08/071,643, and the inventors for this CIP application … PATENTABILITY Since claims 1-4 and 8-2,0 of the ’292 Patent are not patentable over the…each substantial new question of patentability based on prior patents and printed publications External link to document
2008-05-24 70 Exhibit C See 2:4-8; 5:49-54; 6:20-21; 6:33-8:17. ● ’352 Patent: Figs. 2, 3A-B and associated disclosure… • See ’292 Patent at 4:7-19; 10:57-11:27; 11:62- ● ’292 Patent Prosecution History: …the context of its use in the ’352 patent. ● ’292 Patent Prosecution History: Office action…the context of its use in the ’352 patent. ● ’292 Patent Prosecution History, Office action … U.S. Patent No. 7,174,352 Claim No(s). Claim Term External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Baxter
AstraZeneca
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.